Necrosis of uninvolved bone marrow following filgrastim administration in a patient with Burkitt lymphoma undergoing chemotherapy.

Br J Haematol

Hematology Oncology Section, Department of Internal Medicine, Minneapolis VA Medical Center, University of Minnesota, Minneapolis, MN, USA.

Published: October 2012

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12009DOI Listing

Publication Analysis

Top Keywords

necrosis uninvolved
4
uninvolved bone
4
bone marrow
4
marrow filgrastim
4
filgrastim administration
4
administration patient
4
patient burkitt
4
burkitt lymphoma
4
lymphoma undergoing
4
undergoing chemotherapy
4

Similar Publications

Infliximab modifies CD74-mediated lymphatic abnormalities and adipose tissue alterations in creeping fat of Crohn's disease.

Inflamm Res

July 2024

Department of Gastroenterology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, 200072, China.

Background: Lymphatic abnormalities are essential for pathophysiologic changes of creeping fat (CrF) in Crohn's disease (CD). Anti-tumor necrosis factor (TNF) therapy has been proved to alleviate CrF lesions, however, whether it achieves these by remodeling lymphatics is unknown.

Methods: CD74 expression was detected in CrF and uninvolved mesentery of CD patients.

View Article and Find Full Text PDF

Objective: This study aimed to identify hub genes and common pathways shared between psoriasis and cardiovascular disease (CVD) using bioinformatics analysis and predict the transcription factors (TFs) of hub genes.

Methods: GSE133555 data from the Gene Expression Omnibus (GEO) database were used to identify differentially expressed genes (DEGs) between involved and uninvolved skin lesions in psoriasis, employing the limma package in R. Additionally, CVD-related genes were obtained from the GeneCards database.

View Article and Find Full Text PDF

Background: A vascularized fibula graft (VFG) is the vascular autograft most frequently used to restore large segmental long bone defects, particularly in the upper limb. Because the use of a vascularized fibula involves an operation in an uninvolved extremity with potential morbidity, it is important to document that this type of reconstruction is successful in restoring function to the humerus. However, the long-term results of VFG after intercalary resection of the humeral diaphysis for bone tumors are still unknown.

View Article and Find Full Text PDF

Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn's disease.

Therap Adv Gastroenterol

May 2023

Department of Gastroenterology, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Yuelu District, Changsha, Hunan 410013, China.

Background: It remains unclear whether visceral adipose tissue (VAT) can predict the response of patients with Crohn's disease (CD) to anti-tumour necrosis factor-α (anti-TNF-α) therapy.

Objectives: This study aimed to investigate whether VAT predicts the efficacy of infliximab (IFX) for different sites of CD and its relationship with serum TNF-α levels and IFX serum trough concentration.

Design: This is a multicentre retrospective study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!